Vertos Medical has secured $23 million in a Series E funding round led by Pitango Venture Capital. The California-based spinal device company has FDA clearance for a "mild" outpatient procedure intended to enable patients with lumbar spinal stenosis to walk with less pain and stand longer.
AngioDynamics has received investigational device exemption approval from the FDA to conduct a clinical study of its NanoKnife technology, which uses precise ablation to treat patients with localized prostate cancer. The trial will enroll 200 patients from six clinical sites in Europe.
OASIS Medical and Shape Ophthalmics have announced a joint venture to develop and market a shape memory plug that can be used to treat dry eye. The plug, which works using natural body heat, will be manufactured by OASIS and could be available starting next year.
EDAP TMS has earned the CE mark in Europe for its Focal•One robotic High-Intensity Focused Ultrasound device, which is used to treat prostate cancer patients in a noninvasive manner. The device combines MRI with real-time ultrasound imaging to target tumors better during therapy, among other features.